Charles S. Berkman, VP, General Counsel & Secretary at LIGAND PHARMACEUTICALS INC (LGND), sold 11,264 shares at $74.58 ($840K) on 2015-03-16, disclosed to the SEC on 2015-03-18.
Open-market sale of $840k LGND by VP, General Counsel & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.51 | 6,000 | $447K | 53.2% |
| 2 | $74.58 | 1,134 | $85K | 10.1% |
| 3 | $74.58 | 4,130 | $308K | 36.7% |
| Total | $74.54 avg | 11,264 | $840K | 100% |
| Filing → |
| OABI | SELL | 2026-02-17 | $12K | — | Filing → |
| OABI | SELL | 2025-12-09 | $16K | — | Filing → |
| OABI | SELL | 2025-04-07 | $14K | — | Filing → |